(0.21%) 5 165.50 points
(0.17%) 38 898 points
(0.18%) 18 033 points
(1.00%) $78.89
(0.23%) $2.15
(0.78%) $2 326.50
(2.51%) $27.36
(1.06%) $975.50
(-0.03%) $0.929
(-0.31%) $10.84
(-0.28%) $0.795
(-0.11%) $91.35
2.93% $ 2.11
Live Chart Being Loaded With Signals
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States...
Stats | |
---|---|
Volumen de hoy | 553 607 |
Volumen promedio | 643 506 |
Capitalización de mercado | 34.05M |
EPS | $-0.560 ( 2024-02-15 ) |
Próxima fecha de ganancias | ( $-0.660 ) 2024-05-21 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.710 |
ATR14 | $0.0180 (0.86%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-11 | Deveer Robert K Jr | Buy | 6 000 | Common Stock |
2024-03-06 | Deveer Robert K Jr | Sell | 1 685 | Common Stock |
2024-03-06 | Deveer Robert K Jr | Sell | 7 286 | Common Stock |
2024-03-06 | Deveer Robert K Jr | Sell | 200 | Common Stock |
2024-03-06 | Deveer Robert K Jr | Sell | 1 808 | Common Stock |
INSIDER POWER |
---|
47.51 |
Last 100 transactions |
Buy: 594 391 | Sell: 320 931 |
Volumen Correlación
Palatin Technologies Inc Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Palatin Technologies Inc Correlación - Moneda/Commodity
Palatin Technologies Inc Finanzas
Annual | 2023 |
Ingresos: | $4.85M |
Beneficio Bruto: | $4.44M (91.38 %) |
EPS: | $-2.53 |
FY | 2023 |
Ingresos: | $4.85M |
Beneficio Bruto: | $4.44M (91.38 %) |
EPS: | $-2.53 |
FY | 2022 |
Ingresos: | $1.47M |
Beneficio Bruto: | $1.25M (85.19 %) |
EPS: | $-3.75 |
FY | 2021 |
Ingresos: | $-188 597 |
Beneficio Bruto: | $-336 437 (-178.39 %) |
EPS: | $-3.55 |
Financial Reports:
No articles found.
Palatin Technologies Inc
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was incorporated in 1986 and is based in Cranbury, New Jersey.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico